Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Aspects of protein and amino acid metabolism in a model of severe glutamine deficiency in sepsis

Safránek R, Holecek M, Sispera L, Muthný T.

. 2006 ; 50 (4) : 361-367.

Jazyk angličtina Země Švýcarsko

Perzistentní odkaz   https://www.medvik.cz/link/bmc09003583
E-zdroje Online

NLK Karger Journals od 1981 do 2009
ProQuest Central od 2001-03-01 do 2015-11-30
Medline Complete (EBSCOhost) od 1998-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 2001-03-01 do 2015-11-30
Health & Medicine (ProQuest) od 2001-03-01 do 2015-11-30
Family Health Database (ProQuest) od 2001-03-01 do 2015-11-30
Public Health Database (ProQuest) od 2001-03-01 do 2015-11-30

BACKGROUND/AIMS: Growth hormone (GH) could have the potential to improve protein metabolism in sepsis but glutamine deficiency has been reported after GH treatment. The aim was to investigate the effects of glutamine deficiency in sepsis with and without GH treatment on protein and amino acid metabolism. METHODS: Cecal ligation and puncture (CLP) was used as a model of sepsis. Serious glutamine deficiency was induced by administration of glutamine synthetase inhibitor, methionine sulfoximine (MSO). Young Wistar rats were divided into 5 groups: control; CLP; CLP+MSO; CLP+GH, and CLP+MSO+GH. Parameters of protein metabolism were measured on incubated soleus and extensor digitorum longus muscles: [1-14C]leucine was used to estimate protein synthesis and leucine oxidation, tyrosine release was used to evaluate protein breakdown. Amino acid concentrations in plasma, skeletal muscle and incubation media were measured by HPLC. RESULTS/CONCLUSIONS: A reduced muscle glutamine concentration after MSO treatment is not associated with changes in the rates of protein synthesis or breakdown. MSO treatment decreased glutamine release from skeletal muscle and plasma glutamine concentration. Severe glutamine deficiency in GH-treated septic rats resulted in increased release of branched-chain amino acids from skeletal muscle. Copyright 2006 S. Karger AG, Basel.

000      
00000naa 2200000 a 4500
001      
bmc09003583
003      
CZ-PrNML
005      
20111210152808.0
008      
091122s2006 sz e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Šafránek, Roman, $d 1976- $7 xx0038146
245    10
$a Aspects of protein and amino acid metabolism in a model of severe glutamine deficiency in sepsis / $c Safránek R, Holecek M, Sispera L, Muthný T.
314    __
$a Department of Physiology, Faculty of Medicine, Charles University, Hradec Králové, Czech Republic. SafranekR@lfhk.cuni.cz
520    9_
$a BACKGROUND/AIMS: Growth hormone (GH) could have the potential to improve protein metabolism in sepsis but glutamine deficiency has been reported after GH treatment. The aim was to investigate the effects of glutamine deficiency in sepsis with and without GH treatment on protein and amino acid metabolism. METHODS: Cecal ligation and puncture (CLP) was used as a model of sepsis. Serious glutamine deficiency was induced by administration of glutamine synthetase inhibitor, methionine sulfoximine (MSO). Young Wistar rats were divided into 5 groups: control; CLP; CLP+MSO; CLP+GH, and CLP+MSO+GH. Parameters of protein metabolism were measured on incubated soleus and extensor digitorum longus muscles: [1-14C]leucine was used to estimate protein synthesis and leucine oxidation, tyrosine release was used to evaluate protein breakdown. Amino acid concentrations in plasma, skeletal muscle and incubation media were measured by HPLC. RESULTS/CONCLUSIONS: A reduced muscle glutamine concentration after MSO treatment is not associated with changes in the rates of protein synthesis or breakdown. MSO treatment decreased glutamine release from skeletal muscle and plasma glutamine concentration. Severe glutamine deficiency in GH-treated septic rats resulted in increased release of branched-chain amino acids from skeletal muscle. Copyright 2006 S. Karger AG, Basel.
650    _2
$a aminokyseliny $x metabolismus $7 D000596
650    _2
$a zvířata $7 D000818
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glutamin $x analýza $x metabolismus $x nedostatek $7 D005973
650    _2
$a růstový hormon $x farmakologie $7 D013006
650    _2
$a svalové proteiny $x metabolismus $7 D009124
650    _2
$a kosterní svaly $x metabolismus $7 D018482
650    _2
$a náhodné rozdělení $7 D011897
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a sepse $x metabolismus $x patofyziologie $7 D018805
650    _2
$a financování organizované $7 D005381
700    1_
$a Holeček, Milan, $d 1956- $7 xx0010705
700    1_
$a Šišpera, Luděk, $d 1953- $7 xx0076491
700    1_
$a Muthný, Tomáš. $7 _BN002475
773    0_
$w MED00000430 $t Annals of nutrition & metabolism $g Roč. 50, č. 4 (2006), s. 361-367 $x 0250-6807
910    __
$a ABA008 $b A 2868 $y 8
990    __
$a 20090310084605 $b ABA008
991    __
$a 20091128111013 $b ABA008
999    __
$a ok $b bmc $g 692750 $s 554665
BAS    __
$a 3
BMC    __
$a 2006 $b 50 $c 4 $d 361-367 $i 0250-6807 $m Annals of nutrition & metabolism $x MED00000430
LZP    __
$a 2009-B4/ipme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...